title: Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant.
abstract: BACKGROUND
  In a recent study utilizing a saline-lavaged adult rabbit model, we described a significant improvement in systemic oxygenation and pulmonary shunt after the instillation of a novel synthetic peptide-containing surfactant, Synsurf. Respiratory distress syndrome in the preterm lamb more closely resembles that of the human infant, as their blood gas, pH values, and lung mechanics deteriorate dramatically from birth despite ventilator support. Moreover, premature lambs have lungs which are mechanically unstable, with the advantage of being able to measure multiple variables over extended periods. Our objective in this study was to investigate if Synsurf leads to improved systemic oxygenation, lung mechanics, and histology in comparison to the commercially available porcine-derived lung surfactant Curosurf® when administered before first breath in a preterm lamb model.
  
  
  METHODS
  A Cesarean section was performed under general anesthesia on 18 time-dated pregnant Dohne Merino ewes at 129-130 days gestation. The premature lambs were delivered and ventilated with an expiratory tidal volume of 6-8 mL/kg for the first 30 minutes and thereafter at 8-10 mL/kg. In a randomized controlled trial, the two surfactants tested were Synsurf and Curosurf®, both at a dose of 100 mg/kg phospholipids (1,2-dipalmitoyl-L-α-phosphatidylcholine; 90% in Synsurf, 40% in Curosurf®). A control group of animals was treated with normal saline. Measurements of physiological variables, blood gases, and lung mechanics were made before and after surfactant and saline replacement and at 15, 30, 45, 60, 90, 120, 180, 240 and 300 minutes after treatment. The study continued for 5 hours.
  
  
  RESULTS
  Surfactant treatment led to a significant improvement in oxygenation within 30 minutes, with the Synsurf group and the Curosurf® group having significantly higher ratios between arterial partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2; P = 0.021) compared to that of the control (saline-treated) animals. Dynamic compliance improved in the three groups over time, with no intergroup differences. All of the surfactant-treated animals survived, and one in the saline group died before the study ended. Histology between groups was not different, showing mild-moderate injury patterns.
  
  
  CONCLUSIONS
  Treatment with surfactants before first breath clearly resulted in improved systemic oxygenation within 30 minutes of instillation. Both Synsurf- and Curosurf®-treated animals experienced similar and more sustained improvement in oxygenation and decreased calculated shunt compared to saline-treated animals.
authors.affiliation: Division of Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa. jmvzyl@sun.ac.za
authors.forename: Johann M
authors.initials: JM
authors.lastname: van Zyl
authors.forename: Johan
authors.initials: J
authors.lastname: Smith
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001688:Biological Products / Q000494:pharmacology*; D001784:Blood Gas Analysis; D004195:Disease Models, Animal; D010100:Oxygen / Q000378:metabolism*; D010743:Phospholipids / Q000494:pharmacology*; D011663:Pulmonary Surfactants / Q000494:pharmacology*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*; D015656:Respiratory Mechanics / Q000187:drug effects; D012756:Sheep; D013552:Swine; D013990:Tidal Volume; D013997:Time Factors
chemical_list: D001688:Biological Products; D010743:Phospholipids; D011663:Pulmonary Surfactants; C068291:poractant alfa; D010100:Oxygen
keywords: gas exchange; oxygenation; preterm lambs; pulmonary surfactant; respiratory distress syndrome
references.citation: Am J Respir Cell Mol Biol. 2009 Oct;41(4):433-9
references.pmid: 19202005
references.citation: Pediatrics. 2005 Apr;115(4):1018-29
references.pmid: 15805380
references.citation: Pulm Pharmacol. 1993 Dec;6(4):255-62
references.pmid: 8148579
references.citation: Science. 1991 Oct 25;254(5031):566-8
references.pmid: 1948032
references.citation: Biochemistry. 2003 Aug 12;42(31):9446-52
references.pmid: 12899632
references.citation: J Appl Physiol (1985). 1994 Jan;76(1):45-55
references.pmid: 8175544
references.citation: J Clin Invest. 1967 May;46(5):863-73
references.pmid: 6025487
references.citation: Biochemistry. 1986 Jul 15;25(14):4167-74
references.pmid: 3741849
references.citation: Am J Respir Crit Care Med. 1996 Jan;153(1):404-10
references.pmid: 8542150
references.citation: J Appl Physiol (1985). 1997 Oct;83(4):1054-61
references.pmid: 9338410
references.citation: Intensive Care Med. 2004 Jul;30(7):1446-53
references.pmid: 15045168
references.citation: Biochemistry. 1970 Jun 23;9(13):2555-63
references.pmid: 5456729
references.citation: Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1676-95
references.pmid: 18515069
references.citation: J Appl Physiol (1985). 1997 Oct;83(4):1307-17
references.pmid: 9338441
references.citation: Clin Perinatol. 2007 Mar;34(1):145-77, viii
references.pmid: 17394936
references.citation: Paediatr Drugs. 2002;4(8):485-92
references.pmid: 12126452
references.citation: J Biol Chem. 1971 Feb 25;246(4):1142-8
references.pmid: 5543681
references.citation: Reprod Fertil Dev. 1995;7(5):1333-8
references.pmid: 8848608
references.citation: Chem Commun (Camb). 2005 Nov 28;(44):5557-9
references.pmid: 16358062
references.citation: Pediatrics. 1987 Jan;79(1):38-46
references.pmid: 3642431
references.citation: Biopolymers. 1968;6(8):119-36
references.pmid: 5663413
references.citation: J Lipid Res. 1996 Aug;37(8):1749-60
references.pmid: 8864959
references.citation: Biol Neonate. 2004;86(1):1-5
references.pmid: 14739550
references.citation: Biochemistry. 1992 Sep 29;31(38):9169-76
references.pmid: 1390703
references.citation: Am J Perinatol. 2004 Apr;21(3):109-19
references.pmid: 15085492
references.citation: FEBS Lett. 1995 Apr 10;362(3):328-32
references.pmid: 7729523
references.citation: FEBS Lett. 1996 Apr 15;384(2):185-8
references.pmid: 8612820
references.citation: PLoS One. 2012;7(7):e39392
references.pmid: 22808033
references.citation: Am J Respir Crit Care Med. 1998 Feb;157(2):638-44
references.pmid: 9476883
references.citation: N Engl J Med. 2002 Dec 26;347(26):2141-8
references.pmid: 12501227
references.citation: Thorax. 1962 Dec;17(4):320-28
references.pmid: 25269161
references.citation: Biol Neonate. 2004;85(4):285-9
references.pmid: 15218284
references.citation: Pediatr Res. 2012 Oct;72(4):375-83
references.pmid: 22821059
references.citation: Acta Anaesthesiol Scand. 2001 Sep;45(8):986-93
references.pmid: 11576050
references.citation: Am J Physiol. 1992 Mar;262(3 Pt 1):L286-91
references.pmid: 1550251
references.citation: Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7451-5
references.pmid: 1871144
references.citation: Pediatr Res. 2001 Nov;50(5):650-7
references.pmid: 11641462
references.citation: Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1524-33
references.pmid: 11029372
references.citation: Chest. 1994 Mar;105(3 Suppl):57S-62S
references.pmid: 8131614
references.citation: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006069
references.pmid: 17636826
references.citation: J Perinatol. 2008 May;28 Suppl 1:S47-56
references.pmid: 18446178
references.citation: Pept Res. 1989 Sep-Oct;2(5):308-13
references.pmid: 2562485
references.citation: J Biol Chem. 1995 Jul 7;270(27):16225-9
references.pmid: 7608188
references.citation: Drug Des Devel Ther. 2013;7:139-48
references.pmid: 23507973
references.citation: Am J Respir Crit Care Med. 1998 Feb;157(2):553-9
references.pmid: 9476872